Clinical Trial Update: A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating IV casopitant to prevent nausea and vomiting caused by cisplatin-based chemotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer, Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: WITHDRAWN